Private Capital Management Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Private Capital Management demonstrates its value-oriented approach with precise adjustments in the latest 13F filing. Its $1.12B portfolio across 168 positions shows active management, highlighted by massive additions like QuinStreet and trims in core holdings, balancing conviction with portfolio discipline.
Portfolio Snapshot: Diversified Conviction in Small-Cap Value
Portfolio Highlights (Q3’2025): - Market Value: $1,119.7M - Top 10 Holdings: 42.2% - Portfolio Size: 168 +2 - Average Holding Period: 9 quarters - Turnover: 23.8%
Private Capital Management's Q3 2025 portfolio maintains a broad yet focused structure, with the top 10 holdings representing 42.2% of the $1.12 billion total. This concentration in leading positions amid 168 total holdings (+2 new additions) signals confidence in high-conviction names while diversifying across micro- and small-cap opportunities. The 9-quarter average holding period underscores a patient, long-term value strategy, avoiding short-term trading noise.
Turnover at 23.8% reflects deliberate rebalancing rather than reactive shifts, with notable expansions in select growth names and reductions in others to optimize risk-adjusted returns. Managed by Gregg J. Powers, the firm exemplifies disciplined value investing, tracking undervalued businesses through economic cycles. Investors can monitor these dynamics via the full Private Capital portfolio tracker on ValueSense for real-time 13F insights.
This setup—moderate top-10 weighting paired with portfolio breadth—allows flexibility to capitalize on market dislocations while compounding returns from proven winners.
Top Holdings Breakdown: Healthcare Leads with Bold Position Shifts
The portfolio's changes reveal a mix of profit-taking and opportunistic builds, starting with Harrow Health (HROW) at 8.0% after a Reduce 4.61% trim ($89.4M value), maintaining its top rank. A standout move is QuinStreet (QNST) surging to 5.7% via an extraordinary Add 4,515.84% $64.3M, signaling strong conviction in this performance marketing play. Barrett Business Services (BBSI) follows at 3.9% with a significant Reduce 13.97% $43.8M, potentially locking in gains.
Further adjustments include KKR & Co. (KKR) at 3.6% (Reduce 0.76%, $40.8M), Ligand Pharmaceuticals (LGND) also 3.6% (Reduce 0.91%, $40.2M), and ECN Capital Corporation at 3.6% (Reduce 0.18%, $40.0M). Additions continue with BGC Group (BGC) at 3.5% (Add 0.28%, $39.3M) and PowerFleet (AIOT) at 3.4% (Add 9.06%, $38.5M), while Target Hospitality (TH) sits at 3.4% (Reduce 7.02%, $38.3M) and Secure Waste Infrastructure Corp at 3.4% (Reduce 0.40%, $37.5M).
These 10 positions, all featuring changes, dominate the top tier and highlight healthcare (HROW, LGND), business services (BBSI, QNST), and financials (KKR, BGC) as key themes. The massive QNST build and AIOT expansion suggest bets on digital transformation and IoT, balanced by trims in legacy holdings.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
What the Portfolio Reveals About Current Strategy
Private Capital Management's Q3 moves paint a picture of adaptive value investing:
- Healthcare and Niche Services Bias: Top weights in HROW and LGND emphasize undervalued healthcare innovators, with trims indicating valuation discipline.
- Opportunistic Growth Adds: Explosive increases in QNST 4,515.84% and AIOT 9.06% show willingness to scale into high-potential small-caps amid market rotations.
- Risk Management via Breadth: 168 positions dilute single-name risk, while 23.8% turnover prunes underperformers like BBSI -13.97% without abandoning the core.
- Long-Term Orientation: 9-quarter holds favor compounding over speculation, evident in modest tweaks to KKR and BGC.
This blend targets mispriced small/mid-caps with improving fundamentals, navigating volatility through measured conviction.
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Harrow Health, Inc. (HROW) | $89.4M | 8.0% | Reduce 4.61% |
| QuinStreet, Inc. (QNST) | $64.3M | 5.7% | Add 4,515.84% |
| Barrett Business Services, Inc. (BBSI) | $43.8M | 3.9% | Reduce 13.97% |
| KKR & Co. Inc. (KKR) | $40.8M | 3.6% | Reduce 0.76% |
| Ligand Pharmaceuticals Incorporated (LGND) | $40.2M | 3.6% | Reduce 0.91% |
| ECN Capital Corporation | $40.0M | 3.6% | Reduce 0.18% |
| BGC Group, Inc (BGC) | $39.3M | 3.5% | Add 0.28% |
| PowerFleet, Inc. (AIOT) | $38.5M | 3.4% | Add 9.06% |
| Target Hospitality Corp. (TH) | $38.3M | 3.4% | Reduce 7.02% |
| Secure Waste Infrastructure Corp | $37.5M | 3.4% | Reduce 0.40% |
The top 10 command 42.2% of the portfolio, with no single position exceeding 8%, showcasing balanced conviction across diverse small-cap names. Healthcare anchors via HROW, but aggressive adds like QNST's 4,515.84% explosion indicate bold scaling into perceived bargains, while reductions (e.g., BBSI -13.97%, TH -7.02%) demonstrate profit discipline amid a 23.8% turnover.
This structure mitigates volatility in a 168-position book, amplifying alpha from winners like AIOT +9.06% without overexposure. Gregg J. Powers' approach prioritizes quality tweaks over wholesale shifts, ideal for value hunters eyeing 2026 recoveries.
Investment Lessons from Private Capital Management's Approach
Private Capital Management's Q3 portfolio illustrates timeless principles under Gregg J. Powers:
- Scale Conviction Dynamically: The QNST add of 4,515.84% shows building big into validated ideas without hesitation.
- Trim Ruthlessly for Discipline: Reductions like BBSI -13.97% and HROW -4.61% prevent complacency, freeing capital for better opportunities.
- Favor Patience in Small-Caps: 9-quarter holds across 168 positions emphasize fundamental compounding over market timing.
- Balance Breadth with Focus: 42.2% top-10 weighting captures upside while diversification tempers risk.
- Monitor Turnover as a Signal: 23.8% rate flags ongoing optimization, rewarding adaptive managers.
Looking Ahead: What Comes Next?
With two new positions added (portfolio at 168), Private Capital appears poised for further small-cap deployments amid 2026's potential rate stabilization. Cash flexibility from trims (e.g., BBSI, TH) could target healthcare extensions beyond HROW/LGND or digital services like QNST/AIOT. Healthcare tailwinds and business services recovery position core holdings for rerating, while broad diversification hedges macro risks like inflation or slowdowns. Track via ValueSense for Q4 updates.
FAQ about Private Capital Management Portfolio
Q: What were the biggest changes in Private Capital's Q3 2025 13F?
A: Key moves included a massive Add 4,515.84% to QNST 5.7%, Add 9.06% to AIOT 3.4%, offset by trims like BBSI Reduce 13.97% 3.9% and HROW Reduce 4.61% 8.0%.
Q: Why is the portfolio so broad yet top-10 focused?
A: At 168 positions, breadth diversifies small-cap risk, but 42.2% in the top 10 concentrates on highest-conviction value plays, blending scale with prudence.
Q: What sectors dominate Private Capital's strategy?
A: Healthcare (HROW, LGND), business services (BBSI, QNST), and financials (KKR) lead, targeting undervalued niches.
Q: How can I track Private Capital Management's 13F filings?
A: Use ValueSense's tracker at https://valuesense.io/superinvestors/private-capital for holdings, changes, and visuals. Note the 45-day 13F lag—positions may evolve post-filing.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!